You wouldn't have to be an expert on DNA to predict 10 years ago that gene sequencing was likely to increase in importance. That's exactly what happened, with Illumina (NASDAQ:ILMN) leading the way.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,